About this trial
The project involves a 10-year prospective longitudinal cohort multicentre study where orthodontic treatment and treatment effect is followed in children with Cl III due to maxillary retrognathia who undergo standardized orthodontic interceptive treatment. Standard clinical procedures are followed as usual at each clinic where standard diagnostic and follow up materials are taken before treatment, after treatment and follow ups after 5 and 10 years. The project will not introduce or test new treatment modalities, additional procedures or behavioural regulation in relation to normal clinical practice or new medical devices. The standard diagnostic and follow up materials in each clinic include examination of the dentition, occlusion, craniofacial morphology, and orofacial function. The analyses are based on the following standardized registration methods which are carried out on all the patients. Information from the patient record is included.
The patient related outcome measurements will be assessed by five different questionnaires. No biological material is collected for the project.
Eligibility criteria
Qualifiers
Mandibular overjet due to maxillary retrognathia (Overjet </= 0 mm)
Age 9-12 years
Informed consent from parents/guardians
Disqualifiers
Mandibular overjet mainly due to mandibular prognathism
Known general and/or craniofacial syndromes/diseases
Adenoid vegetations, hypertrophic tonsils and significantly reduced air passage through nose (mouth breathing), which must be primarily treated
Functional disorders in muscles and jaw joints, which must be primarily treated
Trial design
Treatments tested in this trial
- Interceptive treatment
Treatment groups
Sponsors and collaborators
Malmö University
Lead sponsor
University of Copenhagen
Collaborator